Adverse Reaction Profile

SUTENT has a well-known safety profile

Go to Important Safety Information

REFERENCES

  1. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356(2):115-124.
  2. Data on file. Pfizer Inc, New York, NY.